These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20147700)

  • 1. A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.
    Sivori S; Falco M; Carlomagno S; Romeo E; Soldani C; Bensussan A; Viola A; Moretta L; Moretta A
    Blood; 2010 Sep; 116(10):1637-47. PubMed ID: 20147700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosis.
    Ghazi B; Thonnart N; Bagot M; Bensussan A; Marie-Cardine A
    J Invest Dermatol; 2015 Jan; 135(1):229-237. PubMed ID: 25007046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging innate NK cell functions with adaptive immunity.
    Marcenaro E; Carlomagno S; Pesce S; Moretta A; Sivori S
    Adv Exp Med Biol; 2011; 780():45-55. PubMed ID: 21842364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).
    Souza-Fonseca-Guimaraes F; Parlato M; de Oliveira RB; Golenbock D; Fitzgerald K; Shalova IN; Biswas SK; Cavaillon JM; Adib-Conquy M
    J Biol Chem; 2013 Apr; 288(15):10715-21. PubMed ID: 23443666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children.
    Capittini C; Emmi G; Mannarino S; Bossi G; Dellepiane RM; Salice P; Pietrogrande MC; Pasi A; De Silvestri A; Tinelli C; Martinetti M
    Eur J Immunol; 2018 Mar; 48(3):543-545. PubMed ID: 29193035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2.
    Niepiekło-Miniewska W; Zuk N; Dubis J; Kurpisz M; Senitzer D; Havrylyuk A; Grendziak R; Witkiewicz W; Chopyak V; Kuśnierczyk P
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):423-9. PubMed ID: 25033772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
    Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
    J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
    Rothenfusser S; Hornung V; Krug A; Towarowski A; Krieg AM; Endres S; Hartmann G
    Eur J Immunol; 2001 Dec; 31(12):3525-34. PubMed ID: 11745372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
    Chan AT; Kollnberger SD; Wedderburn LR; Bowness P
    Arthritis Rheum; 2005 Nov; 52(11):3586-95. PubMed ID: 16255049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
    J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways.
    Qi XF; Zheng L; Kim CS; Lee KJ; Kim DH; Cai DQ; Qin JW; Yu YH; Wu Z; Kim SK
    Mol Immunol; 2013 Jul; 54(3-4):327-37. PubMed ID: 23357786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
    Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas.
    Schmitt C; Marie-Cardine A; Bensussan A
    Front Immunol; 2017; 8():1010. PubMed ID: 28912774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.
    Hatano H; Shaw J; Marquardt K; Zhang Z; Gauthier L; Chanteux S; Rossi B; Li D; Mitchell J; Kollnberger S
    J Immunol; 2015 Feb; 194(4):1591-601. PubMed ID: 25582852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.